John Harry Cross III - Feb 6, 2023 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Chief Financial Officer
Signature
/s/ John Harry Cross III
Stock symbol
SONN
Transactions as of
Feb 6, 2023
Transactions value $
-$2,078
Form type
4
Date filed
2/17/2023, 03:45 PM
Previous filing
Dec 22, 2022
Next filing
Dec 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Tax liability -$2.08K -1.96K -7.57% $1.06 23.9K Feb 6, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes unvested restricted stock units.